文献速递主动脉疾病

101 枚 BeGraft 覆膜支架在开窗腔内修复中作为桥接支架的一年结局

One Year Outcomes of 101 BeGraft Stent Grafts used as Bridging Stents in Fenestrated Endovascular Repairs.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-03-01

单中心前瞻性研究纳入 2015 年 11 月至 2016 年 9 月连续 39 例复杂动脉瘤或 EVAR 后 1 型内漏患者,行开窗腔内修复并使用第二代 BeGraft 作为桥接支架。101 枚 BeGraft 全部成功释放,院内无死亡,早期开窗通畅率 99%(96/97),随访中位 13 个月开窗通畅率 98%(95/97),结论认为一年结局良好,需长期随访确认。

要点

  • 101 枚第二代 BeGraft 桥接支架全部成功释放,院内无死亡。
  • 早期开窗通畅率 99%(96/97),随访中位 13 个月通畅率 98%(95/97)。
  • 术后 1 例靶血管闭塞继发于肾动脉支架远端夹层,该患者术后需透析。

核心结论

  • BeGraft 支架在 FEVAR 中作为桥接支架使用,1 年随访结局良好。
  • 作者认为需长期随访以确认这些有希望的结果。

研究设计与样本

  • 单中心前瞻性研究,连续纳入 2015 年 11 月至 2016 年 9 月接受 FEVAR 并以第二代 BeGraft 作为桥接支架的全部患者。
  • 共 39 例连续患者(其中 1 例女性),使用定制开窗支架(2–5 个开窗)治疗复杂动脉瘤或 EVAR 后 1 型内漏。

主要发现

  • 全部 101 枚 BeGraft 支架成功输送并释放,院内无死亡。
  • 早期开窗通畅率为 99%(96/97)。
  • 唯一一例靶血管术后闭塞继发于肾动脉支架远端夹层,补充支架置入未能恢复肾动脉通畅;同一患者术后 2 个月 CT 显示双侧肾支架闭塞,术后需透析,未观察到其他肾功能损害。
  • 随访中位 13 个月(11–15 个月)期间,所有以 BeGraft 支架置入的开窗均保持通畅(95/97,98%)。
  • 检出并治疗 1 例 1b 型内漏(2.6%)。

局限性

  • 原文结论指出需长期随访以确认这些有希望的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the outcomes of the second generation BeGraft balloon expandable covered stent Graft System (Bentley InnoMed, Hechingen, Germany) implanted as bridging stent grafts during fenestrated endovascular aortic repair (FEVAR) of complex aneurysms. DESIGN: This was a single centre prospective study including all consecutive patients treated by FEVAR performed with second generation BeGraft stent grafts as bridging stents. METHODS: Demographics of patients, diameter and length of the bridging stent grafts, technical success, re-interventions, occlusions, post-operative events, and imaging (Cone Beam CT and/or CT scan, and contrast enhanced ultrasound) were prospectively collected in an electronic database. Duplex ultrasound was performed before discharge and at 6 month follow-up. At 1 year, patients were evaluated clinically and by imaging (CT and ultrasound). RESULTS: Between November 2015 and September 2016, 39 consecutive patients (one woman) were treated with custom made fenestrated endografts (2-5 fenestrations) for complex aneurysms or type 1 endoleak after EVAR, using a variety of bridging stents including the BeGraft. All 101 BeGraft stent grafts were successfully delivered and deployed. There was no in hospital mortality. Early fenestration patency rate was 99% (96/97); the sole target vessel post-operative occlusion was secondary to a dissection of the renal artery distal to the stent. Complementary stenting was unsuccessful in recovering renal artery patency; bilateral renal stent occlusion was observed in the same patient on a CT scan performed 2 months after the procedure. He required post-operative dialysis. No additional renal impairment was observed. During follow-up (median 13 months [11-15]), all fenestrations stented with BeGraft stent grafts remained patent (95/97, 98%). One type 1b endoleak was detected and treated (2.6%). CONCLUSIONS: BeGraft stent grafts used as bridging stents during FEVAR are associated with favourable outcomes at 1 year follow-up. Long-term follow-up is required to confirm these promising results.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Spear R, Sobocinski J, Hertault A, et al. One Year Outcomes of 101 BeGraft Stent Grafts used as Bridging Stents in Fenestrated Endovascular Repairs. Eur J Vasc Endovasc Surg. 2018. PMID: 29501401. doi:10.1016/j.ejvs.2018.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。